Skip to main content

Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2596–2610 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5290
TPM3 Gene Nemaline Myopathy Type 1 Genetic Test

This genetic test analyzes the TPM3 gene for mutations associated with Nemaline Myopathy Type 1.

Whole blood, extracted DNA, or FTA card (peripheral blood) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TPM3 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling", "Submission of a three-generation pedigree chart", "Do not discontinue prescribed medication without consulting your physician"]
Indications
["Suspected Nemaline Myopathy Type 1", "Family history of Nemaline Myopathy Type 1", "Congenital muscle weakness"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94400-5 ICD-10: G71.2
Clinical summary
This genetic test analyzes the TPM3 gene for mutations associated with Nemaline Myopathy Type 1.
TEST-3329
TPMT Genotyping Test

This test evaluates genetic variations in the TPMT gene, which influence the activity of the thiopurine methyltransferase enzyme.

Whole blood (EDTA tube) 3 working days 900.00 AED
View
View test specifications and preparation
What it measures
["TPMT gene variants", "Thiopurine methyltransferase enzyme activity prediction"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions (within 4 weeks)"]
Indications
["Predicting thiopurine drug toxicity risk", "Guiding thiopurine dose adjustments", "Patients with oncology, gastroenterology, or autoimmune diseases requiring thiopurines"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 37011-6 ICD-10: Z13.89
Clinical summary
This test evaluates genetic variations in the TPMT gene, which influence the activity of the thiopurine methyltransferase enzyme.
TEST-5899
TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test

This test evaluates the TPP1 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 7 (SCAR7).

Peripheral Whole Blood or Buccal Swab 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TPP1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the lab of any recent blood transfusions (within 21 days)."]
Indications
["Individuals with clinical features suggestive of SCAR7", "Family history of SCAR7", "Genetic counselling for families with SCAR7"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G11.2
Clinical summary
This test evaluates the TPP1 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 7 (SCAR7).
TEST-5594
TPRN Gene Deafness Autosomal Recessive 79 Genetic Test

This test identifies mutations within the TPRN gene associated with autosomal recessive profound deafness (DFNB79). It uses high-coverage Next-Generation Sequencing to analyze the...

Whole blood (EDTA tube) or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TPRN gene coding region", "±10 base-pair flanking intronic boundaries", "Single-nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed therapy without physician instruction"]
Indications
["Diagnosis of autosomal recessive deafness (DFNB79)", "Recurrence risk counselling for families with hearing loss", "Cochlear implant candidacy assessment", "Early intervention planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: H90.3
Clinical summary
This test identifies mutations within the TPRN gene associated with autosomal recessive profound deafness (DFNB79). It uses high-coverage Next-Generation Sequencing to analyze the entire coding region and flanking intronic boundaries.
TEST-4318
TRAF3 Gene Susceptibility Test (Herpes-Specific Acute Encephalopathy, Type 5)

This test evaluates the TRAF3 gene for variants associated with susceptibility to herpes simplex-triggered acute encephalopathy.

Peripheral whole blood (EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRAF3 gene", "Copy-number variations (CNVs) in the TRAF3 locus"]
Parameters
[]
Preparation
[]
Indications
["Confirmation of molecular diagnosis for TRAF3-related herpes susceptibility", "Guidance for prophylactic antiviral strategies", "Familial risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95053-1 ICD-10: Z13.79
Clinical summary
This test evaluates the TRAF3 gene for variants associated with susceptibility to herpes simplex-triggered acute encephalopathy.
TEST-4747
TRAPPC11 Gene Limb‑Girdle Muscular Dystrophy, Autosomal Recessive Type 2S (LGMD‑2S) Genetic Test

This genetic test identifies variants in the TRAPPC11 gene associated with Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2S (LGMD-2S).

Whole Blood, DNA FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TRAPPC11 gene variants", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"]
Parameters
[]
Preparation
["No fasting required", "No medication discontinuation necessary"]
Indications
["Suspected diagnosis of LGMD-2S", "Family history of LGMD-2S", "Genetic counseling for family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G71.0
Clinical summary
This genetic test identifies variants in the TRAPPC11 gene associated with Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2S (LGMD-2S).
TEST-4807
TRAPPC9 Gene Intellectual Disability (Autosomal Dominant Type 13) Genetic Test

This test identifies pathogenic variants in the TRAPPC9 gene associated with autosomal dominant intellectual disability type 13.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic single-nucleotide variants in TRAPPC9 gene", "Small insertions/deletions (indels) in TRAPPC9 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not alter medications without consulting physician"]
Indications
["Suspected TRAPPC9-related intellectual disability", "Family history of autosomal dominant intellectual disability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101023-7 ICD-10: F79
Clinical summary
This test identifies pathogenic variants in the TRAPPC9 gene associated with autosomal dominant intellectual disability type 13.
TEST-4076
TRDN Gene (Catecholaminergic Polymorphic Ventricular Tachycardia Type 5) Genetic Test

This test identifies pathogenic variants in the TRDN gene associated with catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5).

Peripheral whole blood (3-5 mL) or dried blood spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRDN gene", "Copy Number Variations (CNVs) in the TRDN gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "Complete a three-generation pedigree chart"]
Indications
["Suspected diagnosis of CPVT5", "Family history of CPVT5 or sudden cardiac death", "Evaluation of unexplained syncope or arrhythmias, especially exercise-induced"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21637-4 ICD-10: I47.2
Clinical summary
This test identifies pathogenic variants in the TRDN gene associated with catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5).
TEST-5571
TREM2 Gene Sequencing for Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (Nasu-Hakola Disease) Test

This test analyzes the TREM2 gene for mutations associated with Nasu-Hakola disease (PLOSL). It identifies pathogenic variants causing the disorder.

Peripheral Whole Blood (3–5 mL in EDTA Lavender-Top Tube) 21–28 calendar days (3–4 weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TREM2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed"]
Indications
["Individuals with clinical suspicion of Nasu-Hakola disease (PLOSL)", "Family members of an index patient for cascade screening", "Differential diagnosis of neurodegenerative disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81424-7 ICD-10: E75.2, G31.8
Clinical summary
This test analyzes the TREM2 gene for mutations associated with Nasu-Hakola disease (PLOSL). It identifies pathogenic variants causing the disorder.
TEST-3739
TREX1 Gene Aicardi-Goutières Syndrome Type 1 Genetic Test

This test evaluates the TREX1 gene for pathogenic variants associated with Aicardi-Goutières syndrome type 1.

Peripheral Whole Blood (EDTA) or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TREX1 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"]
Parameters
[]
Preparation
["Do not discontinue prescribed therapy without consulting your physician", "A formal genetic counselling session is required"]
Indications
["Clinical suspicion of Aicardi-Goutières syndrome type 1", "Family history of Aicardi-Goutières syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G04.81
Clinical summary
This test evaluates the TREX1 gene for pathogenic variants associated with Aicardi-Goutières syndrome type 1.
TEST-3695
TRHR Gene Hypothyroidism Genetic Test

This test analyzes the TRHR gene for mutations associated with isolated congenital hypothyroidism.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TRHR gene sequence", "Pathogenic variants (SNVs, indels, splice-site alterations)"]
Parameters
[]
Preparation
["No special preparation required", "Continue regular thyroid medication unless advised otherwise by physician"]
Indications
["Suspected isolated congenital hypothyroidism", "Family history of congenital hypothyroidism", "Need for definitive genetic diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81316-2 ICD-10: E03.1
Clinical summary
This test analyzes the TRHR gene for mutations associated with isolated congenital hypothyroidism.
TEST-3916
TRIM32 Gene (Bardet-Biedl Syndrome Type 11) NGS Test

This test detects pathogenic variants in the TRIM32 gene associated with Bardet-Biedl syndrome type 11.

Whole Blood or FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRIM32 gene"]
Parameters
[]
Preparation
["No fasting or special preparation is required"]
Indications
["Individuals with clinical features suggestive of Bardet-Biedl syndrome type 11", "Family members of affected individuals seeking carrier or predictive testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50397-9 ICD-10: Q87.8
Clinical summary
This test detects pathogenic variants in the TRIM32 gene associated with Bardet-Biedl syndrome type 11.
TEST-5641
TRIOBP Gene Deafness (Autosomal Recessive Type 28) Genetic Test

This test evaluates the TRIOBP gene for pathogenic variants associated with autosomal recessive deafness type 28 (DFNB28). It identifies mutations causing hereditary hearing loss.

Whole blood (EDTA), DNA, or FTA card 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRIOBP gene", "Point mutations", "Small insertions/deletions", "Copy-number variations"]
Parameters
[]
Preparation
["No fasting required", "No medication abstinence required"]
Indications
["Diagnosis of autosomal recessive deafness type 28 (DFNB28)", "Carrier screening in families with a history of DFNB28", "Clarification of hearing loss etiology"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93480-3 ICD-10: H90.5, Z82.2
Clinical summary
This test evaluates the TRIOBP gene for pathogenic variants associated with autosomal recessive deafness type 28 (DFNB28). It identifies mutations causing hereditary hearing loss.
TEST-5454
TRIP11 Gene Achondrogenesis Type 1A Genetic Test (NGS)

This test identifies pathogenic variants in the TRIP11 gene associated with Achondrogenesis Type 1A.

Peripheral whole blood, extracted DNA, or FTA card blood spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRIP11 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No specific patient preparation required"]
Indications
["Confirmation of clinical suspicion of Achondrogenesis Type 1A", "Prenatal diagnosis when family history or ultrasound findings are suggestive"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-0 ICD-10: Q77.1
Clinical summary
This test identifies pathogenic variants in the TRIP11 gene associated with Achondrogenesis Type 1A.
TEST-1067
Trisomy 8 (AML) Test

This diagnostic test evaluates for the presence of an extra copy of chromosome 8 (Trisomy 8) in blood or bone marrow cells, a key prognostic marker in AML.

Bone Marrow (2–3 mL in sodium heparin tube) or Peripheral Blood (5 mL) 3–4 working days 700.00 AED
View
View test specifications and preparation
What it measures
["Chromosome 8 copy number", "Cytogenetic aberration in AML"]
Parameters
[]
Preparation
["No specific fasting required", "Inform physician about all medications, especially chemotherapy, anticoagulants, or immunosuppressants"]
Indications
["Diagnosis of Acute Myeloid Leukaemia (AML)", "Risk stratification in AML", "Minimal Residual Disease (MRD) monitoring in AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53631-7 ICD-10: C92.0
Clinical summary
This diagnostic test evaluates for the presence of an extra copy of chromosome 8 (Trisomy 8) in blood or bone marrow cells, a key prognostic marker in AML.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area